Poor Control Of Anticoagulant Therapy Leads To Increased Adverse Events For Patients With Atrial Fibrillation

Twelve-month data from the Global Anticoagulant Registry in the FIELD (GARFIELD) show that the poor management of stroke prevention therapy is widespread in clinical practice, which may lead to elevated rates of mortality, stroke and bleeding among individuals with newly diagnosed atrial fibrillation (AF). read more

Read the whole article on

More from